Close

PerkinElmer (PKI) Acquires BioLegend for $5.25B

Go back to PerkinElmer (PKI) Acquires BioLegend for $5.25B

PerkinElmer (PKI) PT Raised to $175 at Stifel Following EPS and BioLegend Deal

July 27, 2021 6:18 AM EDT

Stifel analyst Daniel Arias raised the price target on PerkinElmer (NYSE: PKI) to $175.00 (from $155.00) while maintaining a Buy rating.

The analyst commented, "Yesterday, PKI announced another acquisition (the company's 7th announced since Horizon in Nov '20 - though by far the... More

PerkinElmer (PKI) Declares $0.07 Quarterly Dividend; 0.2% Yield

July 23, 2021 4:15 PM EDT

PerkinElmer (NYSE: PKI) declared a quarterly dividend of $0.07 per share, or $0.28 annualized.

The dividend will be payable on November 12, 2021, to stockholders of record on October 22, 2021, with an ex-dividend date of October 21, 2021.

The annual yield on the dividend is 0.2 percent.

For a dividend... More